pre-seed
Stage
1
Investors
About
Keyron develops ForePass®, a fully reversible, non-invasive endoscopic device that replicates metabolic surgery effects to treat severe obesity, type 2 diabetes, NASH, and related metabolic conditions without incisions or tissue perforation.
Explore Keyron's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.